bio-reference labs inc (BFR) Snapshot

Bio-Reference Laboratories Inc. reported unaudited consolidated financial results for the second quarter and six months ended April 30, 2013. For the quarter, the company reported revenues of $176,452,000, representing an increase of 17% over the $151,443,000 recorded in second quarter of fiscal 2012. Operating income was $20,709,000, an increase of 23% over $16,771,000 in second quarter of fiscal 2012. Net income after taxes was at $11,338,000, resulting in earnings per share of $0.41, up from net income after taxes of $9,306,000 and EPS of $0.33 in second quarter of fiscal 2012, increases of 22% and 24%, respectively. Income before taxes was $20,195,000 against $16,401,000 in second quarter of fiscal 2012. Six-month revenues increased to $337,709,000, an increase of 16% over the first six months of fiscal 2012 revenues of $290,236,000. Operating income was $36,468,000, an increase of 21% over fiscal 2012 six-month operating income of $30,055,000. Net income after taxes was $20,003,000 resulting in an EPS of $0.72, an increase of 20% over first six-months fiscal 2012 net income after taxes of $16,671,000, which resulted in an EPS of $0.60. Cash flow from operations was $12,832,000 down from $23,650,000 in the prior year same period. Income before taxes was $35,569,000 against $29,368,000 in the prior year same period.

Bio-Reference Laboratories Inc. Presents at William Blair & Company 33(rd) Annual Growth Stock Conference, Jun-12-2013 04:40 PM. Venue: Four Seasons Hotel, Chicago, Illinois, United States. Speakers: Marc D. Grodman, Founder, Chairman, Chief Executive Officer, President and Managing Director.

Bio-Reference Laboratories Inc., Q2 2013 Earnings Call, Jun 06, 2013